Designates May 2025 as "National Brain Tumor Awareness Month" to raise public awareness, support those affected, and promote collaborative research for better treatments.
Michael McCaul
Representative
TX-10
This resolution expresses support for designating May 2025 as "National Brain Tumor Awareness Month" to raise public awareness, honor those affected, and promote research for better treatments. It highlights the prevalence and severity of brain tumors, the challenges in treatment, and the need for increased awareness and collaborative research efforts. The resolution also supports individuals battling brain tumors, as well as their families, friends, and caregivers.
House Resolution Designates May 2025 "National Brain Tumor Awareness Month", Citing Urgent Need for Research and Support
This House resolution officially recognizes May 2025 as "National Brain Tumor Awareness Month." It's essentially a formal acknowledgement aimed at shining a spotlight on brain tumors, driven by some pretty sobering statistics and the tough realities faced by patients and researchers.
The Reality Check: Why This Matters
The resolution lays out the hard facts: over 93,000 people in the U.S. are expected to get a primary brain tumor diagnosis in 2025, adding to the more than 1 million Americans already living with one. It specifically calls out the devastating impact on younger people – brain tumors are the top cause of cancer deaths for kids under 14 and teens under 19, and the second biggest cause for young adults aged 15-39. Adding to the urgency, the average five-year survival rate for malignant brain tumors is starkly low at just 35.7%, and treatment breakthroughs have been frustratingly slow, with few major advances since the 1980s.
Beyond Awareness: A Call to Action
While designating a month is symbolic, the resolution uses this platform to express the House's strong support for several key goals. It's not just about awareness for awareness' sake; it's about honoring those affected, pushing for the development of better treatments that can improve quality of life and survival odds, and actively supporting the patients, families, and caregivers navigating this difficult journey. Critically, it also urges a more collaborative approach to research, recognizing that tackling the complexities of over 100 different types of brain tumors requires teamwork to speed up understanding and find effective therapies. Think of it as Congress putting an official stamp on the need for more focus, more research, and more support for the brain tumor community.